Eisai Current Ratio 2006-2019 | ESALY

Current and historical current ratio for Eisai (ESALY) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Eisai current ratio for the three months ending December 31, 2019 was .
Eisai Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $4.60B $2.54B 1.81
2019-06-30 $4.44B $2.32B 1.91
2018-06-30 $5.06B $2.30B 2.20
2017-06-30 $4.25B $2.00B 2.12
2016-06-30 $4.26B $1.39B 3.06
2015-06-30 $3.54B $1.32B 2.68
2015-03-31 $4.32B $1.90B 2.27
2014-12-31 $4.30B $1.79B 2.40
2014-09-30 $4.36B $1.81B 2.41
2014-06-30 $4.26B $2.26B 1.89
2014-03-31 $5.03B $1.94B 2.59
2013-12-31 $5.06B $2.11B 2.40
2013-09-30 $4.98B $2.05B 2.43
2013-06-30 $4.75B $1.74B 2.73
2013-03-31 $6.42B $2.61B 2.46
2012-12-31 $6.29B $2.85B 2.21
2012-09-30 $6.10B $2.72B 2.24
2012-06-30 $6.47B $3.49B 1.85
2012-03-31 $6.68B $2.64B 2.53
2011-12-31 $6.61B $2.77B 2.38
2011-09-30 $6.08B $2.42B 2.52
2011-06-30 $5.47B $1.95B 2.81
2011-03-31 $6.14B $2.71B 2.26
2010-12-31 $6.22B $2.90B 2.14
2010-09-30 $5.97B $2.90B 2.06
2010-06-30 $5.27B $2.74B 1.92
2010-03-31 $5.18B $2.38B 2.18
2009-12-31 $5.54B $2.66B 2.08
2009-09-30 $4.94B $2.34B 2.11
2009-06-30 $4.47B $2.25B 1.98
2009-03-31 $4.65B $2.42B 1.92
2008-12-31 $4.41B $2.27B 1.94
2008-09-30 $4.00B $1.89B 2.12
2008-06-30 $4.33B $3.67B 1.18
2008-03-31 $4.16B $5.43B 0.77
2007-12-31 $3.88B $1.85B 2.10
2007-09-30 $3.37B $1.53B 2.20
2007-06-30 $3.17B $1.44B 2.19
2007-03-31 $3.74B $1.63B 2.30
2006-12-31 $3.26B $1.36B 2.40
2006-09-30 $3.84B $1.59B 2.41
2006-06-30 $3.66B $1.42B 2.58
2006-03-31 $3.89B $1.60B 2.43
2005-12-31 $3.68B $1.41B 2.60
2005-09-30 $3.54B $1.39B 2.54
2005-06-30 $3.32B $1.29B 2.57
2005-03-31 $3.42B $1.40B 2.44
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $26.024B $6.400B
Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.486B 42.94
Takeda Pharmaceutical (TAK) Japan $58.483B 10.19
Astellas Pharma (ALPMY) Japan $30.589B 15.50
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.609B 23.09
Catalent (CTLT) United States $13.694B 52.94
Grifols, S.A (GRFS) Spain $12.630B 15.44
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.700B 41.42
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.417B 46.98
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.828B 11.30
United Therapeutics (UTHR) United States $4.858B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $4.369B 0.00
FibroGen (FGEN) United States $4.076B 0.00
Evotec AG (EVTCY) Germany $3.967B 137.87
Hypermarcas (HYPMY) Brazil $3.914B 14.40
ChemoCentryx (CCXI) United States $3.666B 0.00
Nektar Therapeutics (NKTR) United States $3.587B 0.00
PTC Therapeutics (PTCT) United States $3.351B 0.00
Sage Therapeutics (SAGE) United States $2.613B 0.00
Pacira BioSciences (PCRX) United States $2.594B 68.18
Taro Pharmaceutical Industries (TARO) Israel $2.414B 11.69
Cronos Group (CRON) Canada $2.008B 0.00
Xencor (XNCR) United States $1.910B 0.00
Revolution Medicines (RVMD) United States $1.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.786B 0.00
USANA Health Sciences (USNA) United States $1.759B 16.57
Ironwood Pharmaceuticals (IRWD) United States $1.630B 11.37
Indivior (INVVY) United States $1.606B 19.91
Corcept Therapeutics (CORT) United States $1.583B 14.57
Akebia Therapeutics (AKBA) United States $1.523B 0.00
Heron Therapeutics (HRTX) United States $1.439B 0.00
Zogenix (ZGNX) United States $1.376B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.280B 12.20
Karyopharm Therapeutics (KPTI) United States $1.114B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.075B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 619.63
VAXART, INC (VXRT) United States $0.993B 0.00
Esperion Therapeutics (ESPR) United States $0.924B 0.00
Tilray (TLRY) Canada $0.880B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.812B 0.00
Altimmune (ALT) United States $0.780B 0.00
Trillium Therapeutics (TRIL) Canada $0.754B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.717B 1.06
ImmunoGen (IMGN) United States $0.669B 0.00
Collegium Pharmaceutical (COLL) United States $0.619B 0.00
Flexion Therapeutics (FLXN) United States $0.604B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.599B 0.00
Molecular Templates (MTEM) United States $0.590B 0.00
Aerie Pharmaceuticals (AERI) United States $0.576B 0.00
Siga Technologies (SIGA) United States $0.566B 60.42
Radius Health (RDUS) United States $0.562B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.551B 0.00
Ocular Therapeutix (OCUL) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.507B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.491B 24.47
DURECT (DRRX) United States $0.461B 0.00
Organogenesis Holdings (ORGO) United States $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.424B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.353B 8.74
IMV INC (IMV) Canada $0.316B 0.00
Heat Biologics (HTBX) United States $0.312B 0.00
OptiNose (OPTN) United States $0.312B 0.00
Harpoon Therapeutics (HARP) United States $0.311B 0.00
MEI Pharma (MEIP) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.301B 0.00
Calithera Biosciences (CALA) United States $0.301B 0.00
Redhill Biopharma (RDHL) Israel $0.295B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Rafael Holdings (RFL) United States $0.281B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.266B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
Nivalis Therapeutics (ALPN) United States $0.223B 0.00
Aquestive Therapeutics (AQST) United States $0.223B 0.00
KalVista Pharmaceuticals (KALV) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.220B 21.71
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Onconova Therapeutics (ONTX) United States $0.181B 0.00
Xeris Pharmaceuticals (XERS) United States $0.170B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 7.77
Otonomy (OTIC) United States $0.163B 0.00
Lipocine (LPCN) United States $0.136B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
India Globalization Capital (IGC) United States $0.105B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Biomerica (BMRA) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.094B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Addex Therapeutics (ADXN) Switzerland $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.075B 0.00
Sundial Growers (SNDL) Canada $0.074B 0.00
Recro Pharma (REPH) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
PolarityTE (PTE) United States $0.057B 0.00
GTx (ONCT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Natural Alternatives (NAII) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
IsoRay (ISR) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.07
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.032B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Vical (BBI) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 21.31
Flex Pharma (SLRX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00